Anti-HER2 vaccines: new prospects for breast cancer therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1295, doi. 10.1007/s00262-010-0869-2
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2010 AND VI 59 AND IP 9
Results: 15
1
2
Bioactivity and pharmacokinetics of two human serum albumin–thymosin α1-fusion proteins, rHSA-Tα1 and rHSA-L-Tα1, expressed in recombinant Pichia pastoris.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1335, doi. 10.1007/s00262-010-0862-9
- By:
- Publication type:
- Article
3
Inhibition of in vitro tumor cell growth by RP215 monoclonal antibody and antibodies raised against its anti-idiotype antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1347, doi. 10.1007/s00262-010-0864-7
- By:
- Publication type:
- Article
4
MHC-based detection of antigen-specific CD8<sup>+</sup> T cell responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1425, doi. 10.1007/s00262-010-0824-2
- By:
- Publication type:
- Article
5
New strategies for the manipulation of adaptive immune responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1443, doi. 10.1007/s00262-010-0851-z
- By:
- Publication type:
- Article
6
Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1367, doi. 10.1007/s00262-010-0866-5
- By:
- Publication type:
- Article
7
Phenotypic characterization of chronic inflammation in a rare case of endobronchial carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1411, doi. 10.1007/s00262-010-0861-x
- By:
- Publication type:
- Article
8
Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1357, doi. 10.1007/s00262-010-0865-6
- By:
- Publication type:
- Article
9
Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1313, doi. 10.1007/s00262-010-0858-5
- By:
- Publication type:
- Article
10
Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1379, doi. 10.1007/s00262-010-0867-4
- By:
- Publication type:
- Article
11
Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1389, doi. 10.1007/s00262-010-0870-9
- By:
- Publication type:
- Article
12
IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1325, doi. 10.1007/s00262-010-0860-y
- By:
- Publication type:
- Article
13
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1401, doi. 10.1007/s00262-010-0876-3
- By:
- Publication type:
- Article
14
Modeling flow cytometry data for cancer vaccine immune monitoring.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1435, doi. 10.1007/s00262-010-0883-4
- By:
- Publication type:
- Article
15
CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 9, p. 1417, doi. 10.1007/s00262-009-0770-z
- By:
- Publication type:
- Article